Used in biochemical and medical research to quantify levels of UDP-glucuronyltransferase 1A6 enzyme in rat samples. This kit enables researchers to study drug metabolism, detoxification processes, and liver function in preclinical studies. It is particularly useful in assessing the impact of pharmaceuticals, toxins, or disease states on phase II metabolic pathways. The assay supports high-throughput analysis with high sensitivity and specificity, making it ideal for use in pharmacokinetic and toxicology research.